Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giles Davis

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2011
Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone miceMarcio O Lasaro, Marina Sazanovich, Wynetta Giles-Davis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2012
Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virusDongming Zhou, Te-Lang Wu, Kristel L Emmer, et al.
Journal of Virology|April 13, 2007
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectorsKimberly McCoy, Nia Tatsis, Birgit Korioth-Schmitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimensNia Tatsis, Marcio O Lasaro, Shih-Wen Lin, et al.
Cancer Cell|September 13, 2017
Enhancing CD8<sup>+</sup> T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma ImmunotherapyYing Zhang, Raj Kurupati, Ling Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaquesMarcio O Lasaro, Larissa H Haut, Xiangyang Zhou, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2011
Active immunotherapy combined with blockade of a coinhibitory pathway achieves regression of large tumor masses in cancer-prone miceMarcio O Lasaro, Marina Sazanovich, Wynetta Giles-Davis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2012
Hexon-modified recombinant E1-deleted adenovirus vectors as dual specificity vaccine carriers for influenza virusDongming Zhou, Te-Lang Wu, Kristel L Emmer, et al.
Journal of Virology|April 13, 2007
Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectorsKimberly McCoy, Nia Tatsis, Birgit Korioth-Schmitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Adenovirus vector-induced immune responses in nonhuman primates: responses to prime boost regimensNia Tatsis, Marcio O Lasaro, Shih-Wen Lin, et al.
Cancer Cell|September 13, 2017
Enhancing CD8<sup>+</sup> T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma ImmunotherapyYing Zhang, Raj Kurupati, Ling Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Vaccine-induced T cells provide partial protection against high-dose rectal SIVmac239 challenge of rhesus macaquesMarcio O Lasaro, Larissa H Haut, Xiangyang Zhou, et al.
Pageof 4